title: Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes.
authors: Department of Medicine and Cardiology Unit, University of Rochester Medical Center, Rochester, New York 14642, USA. donald_cutlip@urmc.rochester.edu
authors: D E
authors: DE
authors: Cutlip
authors: C J
authors: CJ
authors: Cove
authors: D
authors: D
authors: Irons
authors: V
authors: V
authors: Kalaria
authors: M
authors: M
authors: Le
authors: H
authors: H
authors: Cronmiller
authors: L
authors: L
authors: Caufield
authors: R M
authors: RM
authors: Pomerantz
authors: F S
authors: FS
authors: Ling
mesh_terms: D017130:Angioplasty; D016009:Chi-Square Distribution; D003326:Coronary Circulation / Q000187:drug effects; D004636:Emergency Service, Hospital; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000628:therapy; D015425:Myocardial Reperfusion; D010455:Peptides / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide